A big pharma company, ValiRx, entered into a partnership with the university and hospital to further evaluate the findings, i.e. initial findings are encouraging but needs more in-depth clinical research. So could be much ado about nothing after further research.
And with the hospital and university doing all the clinical research the pharma. company saves time and money if the findings come to any fruition.
If successful they can use on the findings of the hospital and university to cash in due to their joint venture agreement with them. So basically the taxpayers of Britain are financing the research through the university and hospital. ValiRx is avoiding the upfront expenses since the university and hospital are doing it. ValiRx takes a short cut to the marketplace if the therapy becomes a true avenue to attack cancer. If it becomes marketable they will gouge US patients since Europe and Canada are government controlled healthcare. As we have seen here in the US, pharma. companies are doing the same thing here using US universities to do the research and trials. Some even contract with doctors to do the clinical research since the doctors have a group of patients to chose from for clinical research.
Oncology is expensive and a big money maker in the US healthcare arena.